A global consortium designed to gather information on patients with thoracic cancer infected with COVID-19 regardless of therapies administered.
The initiative currently involves more than 100 investigators worldwide. Main contact: Jennifer Whisenant, Vanderbilt-Ingram Cancer Center, Nashville, US. - E-Mail
